CytoDyn Inc. (CYDY)
OTCMKTS
· Delayed Price · Currency is USD
0.220
0.00 (0.05%)
Jan 23, 2025, 4:00 PM EST
CytoDyn Cash Flow Statement
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 30, 2024 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | May '20 May 31, 2020 | 2019 - 2015 |
| Net Income | -14.25 | -49.84 | -79.82 | -210.82 | -176.47 | -139.94 | Upgrade
|
| Depreciation & Amortization | 0.02 | 0.03 | 0.18 | 0.78 | 1.8 | 2.03 | Upgrade
|
| Other Amortization | 0.98 | 1.65 | 2.2 | 3.05 | 3.66 | 2.05 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 10.05 | - | Upgrade
|
| Stock-Based Compensation | 2.01 | 2.42 | 4.28 | 6.24 | 10.43 | 6.55 | Upgrade
|
| Other Operating Activities | 17.01 | 23.11 | 49.26 | 127.81 | 58.08 | 62.09 | Upgrade
|
| Change in Accounts Receivable | - | - | - | - | - | 0.09 | Upgrade
|
| Change in Inventory | - | - | - | 2.06 | -79.36 | -19.15 | Upgrade
|
| Change in Accounts Payable | -6.86 | 10.77 | -3.1 | -2.71 | 53.01 | 19.04 | Upgrade
|
| Change in Other Net Operating Assets | -1.05 | 0.89 | 1.9 | -4.13 | 1.23 | -1.58 | Upgrade
|
| Operating Cash Flow | -2.13 | -10.98 | -25.11 | -77.72 | -117.57 | -68.8 | Upgrade
|
| Capital Expenditures | - | - | - | - | -0.12 | -0.04 | Upgrade
|
| Investing Cash Flow | - | - | - | - | -0.12 | -0.04 | Upgrade
|
| Long-Term Debt Issued | - | 2.31 | 0.9 | - | 100 | 15 | Upgrade
|
| Total Debt Issued | 0.95 | 2.31 | 0.9 | - | 100 | 15 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -0.95 | -2.19 | Upgrade
|
| Total Debt Repaid | -0.71 | - | - | - | -0.95 | -2.19 | Upgrade
|
| Net Debt Issued (Repaid) | 0.24 | 2.31 | 0.9 | - | 99.05 | 12.82 | Upgrade
|
| Issuance of Common Stock | 6.12 | 9.44 | 26.23 | 42.62 | 22.27 | 56.69 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -0.78 | -0.09 | Upgrade
|
| Preferred Dividends Paid | - | - | - | - | -0.24 | - | Upgrade
|
| Dividends Paid | - | - | - | - | -0.24 | - | Upgrade
|
| Other Financing Activities | 10.38 | - | 2.81 | 5.39 | 17.05 | -3.16 | Upgrade
|
| Financing Cash Flow | 16.74 | 11.75 | 29.93 | 48.01 | 137.35 | 79.67 | Upgrade
|
| Net Cash Flow | 14.61 | 0.77 | 4.82 | -29.71 | 19.65 | 10.83 | Upgrade
|
| Free Cash Flow | -2.13 | -10.98 | -25.11 | -77.72 | -117.7 | -68.85 | Upgrade
|
| Free Cash Flow Margin | - | - | - | -29219.17% | - | - | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.03 | -0.11 | -0.20 | -0.16 | Upgrade
|
| Cash Interest Paid | 0.03 | 0.05 | 0.02 | 0.06 | 0.15 | - | Upgrade
|
| Levered Free Cash Flow | -38.65 | -43.05 | -31.93 | -102.87 | 15.22 | -58.13 | Upgrade
|
| Unlevered Free Cash Flow | -35.76 | -39.28 | -24.44 | -90.8 | 25.38 | -39.4 | Upgrade
|
| Change in Net Working Capital | 43 | 30.43 | 3.53 | 6.96 | -72.37 | 1.29 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.